Barbara C. Gärtner - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Barbara C. Gärtner's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Barbara C. Gärtner
Verified
Lead Text Editor, AD Magazin
Munich
Beats
current affairs german politics germanyinternational news
I typically cover anything...just ask!
Content
SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals - Nature Communications
By Saskia Bronder, Sophie Schneitler, Sören L. Becker, Barbara C. Gärtner, Leonardo Martinez, Marek Widera, Tina Schmidt| Nature Verified AbstractKnowledge is limited as to how prior SARS-CoV-2 infection influences cellular and humoral immunity after booster-vaccination with bivalent BA.4/5-adapted mRNA-vaccines, and whether vaccine-induced immunity may indicate subsequent infection. In this observational study, individuals with prior infection (n = 64) showed higher vaccine-induced anti-spike IgG-antibodies and neutralizing titers, but the relative increase was significantly higher in non-infected individuals (n = 63).
Dental aerosol-producing treatments: Comparison of contamination patterns of face shields and surgical masks
By Matthias Hannig, Barbara C. Gärtner, Stefan Rupf, Alexander Halfmann| Taylor & Francis@ AbstractDuring the COVID-19 pandemic, dental face shields were recommended to protect the eyes. This study aimed to examine to what extent face shield and mask contamination differ when a pre-procedural mouth rinsing with Chlorhexidine (CHX) is conducted before treatment. In this prospective, randomized study, three groups of subjects were formed (rinsing with 0.1% CHX, water, or no rinsing (control) before aerosol-producing treatments).
SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals - Nature Communications
By Saskia Bronder, Sophie Schneitler, Sören L. Becker, Barbara C. Gärtner, Leonardo Martinez, Marek Widera, Tina Schmidt| Nature Verified AbstractKnowledge is limited as to how prior SARS-CoV-2 infection influences cellular and humoral immunity after booster-vaccination with bivalent BA.4/5-adapted mRNA-vaccines, and whether vaccine-induced immunity may indicate subsequent infection. In this observational study, individuals with prior infection (n = 64) showed higher vaccine-induced anti-spike IgG-antibodies and neutralizing titers, but the relative increase was significantly higher in non-infected individuals (n = 63).
Company Info
AD Magazin